Related Experiment Videos
Predicting outcome in hematological stem cell transplantation.
Anne M Dickinson1, James Cavet, Hannah Cullup
1University Department Haematology, Tyneside Leukemia Research Laboratory, Royal Victoria Infirmary, Queen Victoria Road, Newcastle upon Tyne, UK. a.m.dickinson@ncl.ac.uk
Archivum Immunologiae Et Therapiae Experimentalis
|January 28, 2003
Summary
Cytokine gene variations, like TNF-alpha and IL-10, may predict outcomes in allogeneic stem cell transplants. Specific polymorphisms are linked to increased risk and severity of graft versus host disease (GvHD).
Area of Science:
- Immunogenetics
- Transplantation immunology
- Molecular biology
Background:
- Allogeneic stem cell transplantation (ASCT) is a critical treatment for various hematologic malignancies.
- Graft versus host disease (GvHD) remains a major complication following ASCT, significantly impacting patient outcomes.
- Genetic factors, particularly cytokine gene polymorphisms, are increasingly recognized for their potential role in ASCT success and complications.
Purpose of the Study:
- To review recent findings on the association between cytokine gene polymorphisms and outcomes in allogeneic stem cell transplantation.
- To explore the utility of these polymorphisms in predicting graft versus host disease (GvHD) risk and severity.
- To discuss the development of a genetic risk index for GvHD in HLA-matched sibling transplants.
Main Methods:
- Review of existing literature on cytokine gene polymorphisms (TNF-alpha, IFN-gamma, IL-6, IL-10, IL-1Ra) in ASCT.
- Analysis of studies investigating the predictive value of these polymorphisms for transplant outcomes.
- Utilizing an in vitro human skin explant model to assess disease severity associated with specific polymorphisms.
Main Results:
- Certain cytokine gene polymorphisms, including Tumor Necrosis Factor-alpha (TNF-alpha) and Interleukin-10 (IL-10), show potential in predicting transplant outcomes.
- These genetic variations are associated with the development and severity of graft versus host disease (GvHD).
- Initial findings from an in vitro model suggest a link between specific polymorphisms and more severe GvHD.
Conclusions:
- Cytokine gene polymorphisms represent a significant area of research for optimizing allogeneic stem cell transplantation.
- Genetic profiling, including cytokine gene polymorphisms, may aid in developing risk stratification tools for GvHD.
- Further research is warranted to validate these findings and integrate genetic markers into clinical practice for improved ASCT patient management.